IBDEI0R3 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27219,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,27219,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,27219,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,27220,0)
 ;;=F02.80^^102^1318^45
 ;;^UTILITY(U,$J,358.3,27220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27220,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,27220,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,27220,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,27221,0)
 ;;=G31.84^^102^1318^62
 ;;^UTILITY(U,$J,358.3,27221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27221,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,27221,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,27221,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,27222,0)
 ;;=A81.9^^102^1318^71
 ;;^UTILITY(U,$J,358.3,27222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27222,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,27222,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,27222,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,27223,0)
 ;;=F02.81^^102^1318^32
 ;;^UTILITY(U,$J,358.3,27223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27223,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,27223,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,27223,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,27224,0)
 ;;=F02.80^^102^1318^33
 ;;^UTILITY(U,$J,358.3,27224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27224,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,27224,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,27224,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,27225,0)
 ;;=G31.84^^102^1318^63
 ;;^UTILITY(U,$J,358.3,27225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27225,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PRION DISEASE
 ;;^UTILITY(U,$J,358.3,27225,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,27225,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,27226,0)
 ;;=S06.2X9S^^102^1318^74
 ;;^UTILITY(U,$J,358.3,27226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27226,1,3,0)
 ;;=3^TRAUMATIC BRAIN INJURY,Diffuse w/ Unspec Duration of LOC,Sequela
 ;;^UTILITY(U,$J,358.3,27226,1,4,0)
 ;;=4^S06.2X9S
 ;;^UTILITY(U,$J,358.3,27226,2)
 ;;=^5020755
 ;;^UTILITY(U,$J,358.3,27227,0)
 ;;=F02.81^^102^1318^50
 ;;^UTILITY(U,$J,358.3,27227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27227,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,27227,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,27227,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,27228,0)
 ;;=F02.80^^102^1318^51
 ;;^UTILITY(U,$J,358.3,27228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27228,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,27228,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,27228,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,27229,0)
 ;;=G31.84^^102^1318^64
 ;;^UTILITY(U,$J,358.3,27229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27229,1,3,0)
 ;;=3^Mild Neurocog D/O d/t TBI
 ;;^UTILITY(U,$J,358.3,27229,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,27229,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,27230,0)
 ;;=F01.51^^102^1318^48
 ;;^UTILITY(U,$J,358.3,27230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27230,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,27230,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,27230,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,27231,0)
 ;;=F01.50^^102^1318^49
 ;;^UTILITY(U,$J,358.3,27231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27231,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,27231,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,27231,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,27232,0)
 ;;=G31.84^^102^1318^65
 ;;^UTILITY(U,$J,358.3,27232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27232,1,3,0)
 ;;=3^Mild Neurocog D/O d/t VASCULAR DISEASE
 ;;^UTILITY(U,$J,358.3,27232,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,27232,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,27233,0)
 ;;=R41.9^^102^1318^68
 ;;^UTILITY(U,$J,358.3,27233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27233,1,3,0)
 ;;=3^Neurocognitive Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,27233,1,4,0)
 ;;=4^R41.9
 ;;^UTILITY(U,$J,358.3,27233,2)
 ;;=^5019449
 ;;^UTILITY(U,$J,358.3,27234,0)
 ;;=F06.31^^102^1319^1
 ;;^UTILITY(U,$J,358.3,27234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27234,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Depressive Features
 ;;^UTILITY(U,$J,358.3,27234,1,4,0)
 ;;=4^F06.31
 ;;^UTILITY(U,$J,358.3,27234,2)
 ;;=^5003057
 ;;^UTILITY(U,$J,358.3,27235,0)
 ;;=F06.32^^102^1319^2
 ;;^UTILITY(U,$J,358.3,27235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27235,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Major Depressive-Like Episode
 ;;^UTILITY(U,$J,358.3,27235,1,4,0)
 ;;=4^F06.32
 ;;^UTILITY(U,$J,358.3,27235,2)
 ;;=^5003058
 ;;^UTILITY(U,$J,358.3,27236,0)
 ;;=F32.9^^102^1319^20
 ;;^UTILITY(U,$J,358.3,27236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27236,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,27236,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,27236,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,27237,0)
 ;;=F32.0^^102^1319^17
 ;;^UTILITY(U,$J,358.3,27237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27237,1,3,0)
 ;;=3^MDD,Single Episode,Mild
 ;;^UTILITY(U,$J,358.3,27237,1,4,0)
 ;;=4^F32.0
 ;;^UTILITY(U,$J,358.3,27237,2)
 ;;=^5003521
 ;;^UTILITY(U,$J,358.3,27238,0)
 ;;=F32.1^^102^1319^18
 ;;^UTILITY(U,$J,358.3,27238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27238,1,3,0)
 ;;=3^MDD,Single Episode,Moderate
 ;;^UTILITY(U,$J,358.3,27238,1,4,0)
 ;;=4^F32.1
 ;;^UTILITY(U,$J,358.3,27238,2)
 ;;=^5003522
 ;;^UTILITY(U,$J,358.3,27239,0)
 ;;=F32.2^^102^1319^19
 ;;^UTILITY(U,$J,358.3,27239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27239,1,3,0)
 ;;=3^MDD,Single Episode,Severe
 ;;^UTILITY(U,$J,358.3,27239,1,4,0)
 ;;=4^F32.2
 ;;^UTILITY(U,$J,358.3,27239,2)
 ;;=^5003523
 ;;^UTILITY(U,$J,358.3,27240,0)
 ;;=F32.3^^102^1319^14
 ;;^UTILITY(U,$J,358.3,27240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27240,1,3,0)
 ;;=3^MDD,Single Episode w Psychotic Features
 ;;^UTILITY(U,$J,358.3,27240,1,4,0)
 ;;=4^F32.3
 ;;^UTILITY(U,$J,358.3,27240,2)
 ;;=^5003524
 ;;^UTILITY(U,$J,358.3,27241,0)
 ;;=F32.4^^102^1319^16
 ;;^UTILITY(U,$J,358.3,27241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27241,1,3,0)
 ;;=3^MDD,Single Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,27241,1,4,0)
 ;;=4^F32.4
 ;;^UTILITY(U,$J,358.3,27241,2)
 ;;=^5003525
 ;;^UTILITY(U,$J,358.3,27242,0)
 ;;=F32.5^^102^1319^15
 ;;^UTILITY(U,$J,358.3,27242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27242,1,3,0)
 ;;=3^MDD,Single Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,27242,1,4,0)
 ;;=4^F32.5
 ;;^UTILITY(U,$J,358.3,27242,2)
 ;;=^5003526
 ;;^UTILITY(U,$J,358.3,27243,0)
 ;;=F33.9^^102^1319^13
 ;;^UTILITY(U,$J,358.3,27243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27243,1,3,0)
 ;;=3^MDD,Recurrent Episode,Unspec
 ;;^UTILITY(U,$J,358.3,27243,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,27243,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,27244,0)
 ;;=F33.0^^102^1319^10
 ;;^UTILITY(U,$J,358.3,27244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27244,1,3,0)
 ;;=3^MDD,Recurrent Episode,Mild
 ;;^UTILITY(U,$J,358.3,27244,1,4,0)
 ;;=4^F33.0
 ;;^UTILITY(U,$J,358.3,27244,2)
 ;;=^5003529
 ;;^UTILITY(U,$J,358.3,27245,0)
 ;;=F33.1^^102^1319^11
 ;;^UTILITY(U,$J,358.3,27245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27245,1,3,0)
 ;;=3^MDD,Recurrent Episode,Moderate
 ;;^UTILITY(U,$J,358.3,27245,1,4,0)
 ;;=4^F33.1
 ;;^UTILITY(U,$J,358.3,27245,2)
 ;;=^5003530
 ;;^UTILITY(U,$J,358.3,27246,0)
 ;;=F33.2^^102^1319^12
